Brief: Xspray Pharma Re-Submits FDA Application
08/04/2025 06:41
April 8 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST: RE-SUBMITS ITS FDA APPLICATION FDA EXPECTED TO ANNOUNCE NEW PDUFA DATE FOR DASYNOC IN 2-4 WEEKS Source text: ID:nMFN90WMHH Further company coverage: XSPRAY.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003